BGMSP
Apollo Global Management, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$1.10
+0.00%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -89.8%
- EBITDA
- +52.8%
- EBIT
- +52.8%
- Net income
- +50.3%
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026